Quick Research
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 27,713 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
18F-labeled FGFR1 peptide: a new PET probe for subtype FGFR1 receptor imaging (2023-04-27)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: A549 [A-549] Cells Line, RT-112 Cells Line -
Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer (2023-02-02)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: MCF 10A Cell Complete Medium -
Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model (2023-06-15)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: U251 Cells Line, U-87 MG Cells Line, Human Astrocyte cells -
Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity (2023-04-14)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: K-562 [K562] Cells Line, CCRF-CEM [CCRF CEM] Cells Line -
Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer (2023-04-03)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: Ham's F-12K Medium -
Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer (2023-05-12)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: AsPC-1 Cells Line, CFPAC-1 Cells Line, PANC-1 Cells Line, IMDM, DMEM(High glucose), Fetal Bovine Serum, Penicillin-Streptomycin Solution, 100× -
Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma (2023-05-05)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: RCC Cells Line -
Tumor-associated M2 macrophages in the immune microenvironment influence the progression of renal clear cell carcinoma by regulating M2 macrophage-associated genes (2023-06-08)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: 786-O [786-0] Cells Line, HK-2 Cells Line, THP-1 Cells Line, Fetal Bovine Serum -
Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment (2023-06-08)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: MG-63 Cells Line, U-2 OS [U2OS] Cells Line, HOS Cells Line, K7M2 wt [K7M2-WT] Cells Line, RAW 264.7 Cells Line -
Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function (2023-07-06)
Journal: Frontiers in Oncology (2023) IF: 4.7Products Cited: 786-O [786-0] Cells Line, 769-P Cells Line, HK-2 Cells Line
